Webinar | Available On Demand
Go “around the world” with updates on global market access
Based on Trinity’s 3rd Annual State of Global Market Access white paper, this webinar will take you “around the world” with focused updates on the US, Europe, Asia Pacific, and Latin America. Trinity experts will connect policy and access developments to practical implications for launch sequencing, evidence planning, pricing strategies, and in‑line optimization so teams can pressure‑test current plans and prepare for what’s next.
Engage in the conversation
Attendees can also influence the discussion by submitting a question in advance of the webinar using the form below.
Key webinar topics
- United States
Evolving implications of MFN and TrumpRx, and how shifting price benchmarks and federal platforms are shaping launch, lifecycle management, and channel strategies. - Europe
Regulatory–HTA convergence through EU Joint Clinical Assessment and UK parallel MHRA–NICE reviews, and the implications of these changes for evidence requirements, timelines, and value communication. - Asia Pacific
Transition to a multi-tier funding model, NRDL value-based negotiations, the Commercial Innovative Drug List (Category C), along with the growing role of real-world evidence and early access platforms. - Latin America
HTA and pricing reforms, the increasing focus on local manufacturing and technology transfer, and emerging considerations for high-cost therapies, including cell and gene therapies. - Cross-regional implications
How these trends collectively impact launch sequencing, portfolio strategy, contracting approaches, and global value narratives for pharma, biotech, and medtech companies.
Complete the form below to view the on-demand webinar:
By clicking "I agree" above, you are agreeing that Trinity will use and protect your personal data in accordance with our Privacy Policy. You can opt out of future marketing communications at any time by clicking the unsubscribe link at the bottom of any marketing email you receive from Trinity.
